AstraZeneca furthers US manufacturing commitment with $2bn Maryland investment
The move is part of biopharma's $50 billion pledge to US medicines manufacturing and R&D.
List view / Grid view
The move is part of biopharma's $50 billion pledge to US medicines manufacturing and R&D.
The pharmaceutical laboratory meeting adds sessions on AI in labs, and quality in biologics, mRNA and analytics.
Following 2025’s event in Frankfurt, Informa’s flagship pharma exhibition will next year include an area for artificial intelligence.
Cultural change inside pharma needed to help attract tech talent and support a deeper adoption of AI in the industry, say recruiters at CPHI Frankfurt 2025.
Speaking at CPHI Frankfurt, Bruno Fabre underlined the importance of companies viewing the technology as a fundamental business capability, rather than “an afterthought”.
Pharma giant plans to harness its “decades of data” and use AI to set a new scientific standard that accelerates pharmaceutical innovation.
Establishes Resource for AI Science in Europe and eyes frontier AI models and autonomous agentic AI for pharma.
Pistoia Alliance survey also found that the greatest benefit for lab digitalisation has shifted from efficiency to innovation.
The new $6.5 billion Houston site will manufacture active pharmaceutical ingredients (APIs) in support of the company’s pipeline of small molecule medicines.
This in-depth focus features articles on rapid microbiological methods, quality control, and using AI to read agar plates.
EPR Issue 3 includes articles on microbiology, downstream processing, manufacturing, drug formulation and more.
The new $5 billion manufacturing site is set to become the company’s first integrated facility for API and drug product manufacturing.
Expanding its collaboration with the US biotech will add novel molecular glue degrader-based medicines to the pharma company’s pipeline.
Says the Bay Area building’s digital infrastructure will make it one of biopharma’s leading artificial intelligence-powered centres.
Significant investment in advanced technologies Is expected to support global adoption of mass spectrometry in the next five years.